BUZZ-U.S. Stocks on the Move-Novogen, Tetralogic, oil companies, BBX, Cyclacel, Talisman
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks rose in a volatile Tuesday session as energy shares rallied and investors bet the Federal Reserve will be cautious in removing support in the face of a more fragile global economy.
The Dow Jones industrial average was up 0.64 percent at 17,290.27, the S&P 500 was up 0.56 percent at 2,000.78 and the Nasdaq Composite was up 0.20 percent at 4,614.425.
** NOVOGEN LTD, $4.91, +187.13 pct
The Australian drug developer said its brain cancer drug, TRXE-009, was also found to be effective in treating a kind of skin cancer in pre-clinical studies.
** TETRALOGIC PHARMACEUTICALS CORP, $4.54, -22.39 pct
The drug developer lowered dosage of ovarian cancer drug in early-stage study after adverse events were reported. The drug, tested in combination with Amgen's conatumumab, led to adverse events at doses lower than expected.